Net Sales Royalty Percentage

No definition available.

Name:	mbot_NetSalesRoyaltyPercentage
Namespace Prefix:	mbot_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Participation Percentage

+ References

No definition available.

+ Details

Name:	mbot_ParticipationPercentage
Namespace Prefix:	mbot_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 730
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_RevenueFromGrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mbot_IsraeliInnovationAuthorityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mbot_ChiefScientistOfStateOfIsraelMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_IL
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=mbot_OthersCountryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mbot_TheTechnicianResearchAndDevelopmentFoundationLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments (Detail)			1 Months Ended				3 Months Ended		5 Months Ended		6 Months Ended		9 Months Ended		12 Months Ended				17 Months Ended	22 Months Ended
Commitments (Detail)	Mar. 29, 2016 USD ($)	Mar. 29, 2016 ILS (₪)	Aug. 31, 2014 USD ($)	Aug. 31, 2014 ILS (₪)	Jun. 30, 2012 USD ($)	Jun. 30, 2012 ILS (₪)	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2014 ILS (₪)	Dec. 31, 2012 USD ($)	Dec. 31, 2012 ILS (₪)	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013	Jun. 30, 2012	Sep. 30, 2015	Apr. 30, 2014
Loss Contingencies [Line Items]
Research and development expense							$ 340,051	$ 15,613					$ 602,575	$ 477,607	$ 822,759	$ 836,698
Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Royalties payable as % of future sales													3.00%		3.00%	3.00%	3.00%
Total grants obtained													$ 893,673		$ 705,930
Research and development expense, CS participation percentage																			50.00%
Refund for participation research and development									$ 400,143	₪ 1,554,156
Chief Scientist Of State Of Israel [Member]
Loss Contingencies [Line Items]
Research and development expense, CS participation percentage																				50.00%
Refund for participation research and development											$ 305,787	₪ 1,189,204
ISRAEL \| Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Research and development expense, CS participation percentage	60.00%	60.00%
Outside of Israel [Member] \| Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Research and development expense, CS participation percentage	30.00%	30.00%
Refund for participation research and development	$ 187,743	₪ 725,826
Minimum [Member] \| The Technician Research And Development Foundation Limited [Member]
Loss Contingencies [Line Items]
Royalties payable as % of future sales																		1.50%
Maximum [Member] \| The Technician Research And Development Foundation Limited [Member]
Loss Contingencies [Line Items]
Royalties payable as % of future sales																		3.00%
Maximum [Member] \| Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Research and development expense			$ 924,166	₪ 3,594,082
Maximum [Member] \| Chief Scientist Of State Of Israel [Member]
Loss Contingencies [Line Items]
Research and development expense					$ 764,466	₪ 2,973,010
Maximum [Member] \| ISRAEL \| Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Research and development expense	794,963	3,041,529
Maximum [Member] \| Outside of Israel [Member] \| Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Research and development expense	$ 215,630	₪ 825,000